1. Pink Sheet
  2. >>Geography

Why Generic EpiPen Is Not The Answer – Until FDA Says It Is

 
• By Michael McCaughan

There is no question that the concerns over Mylan’s price increases for EpiPen would deflate as rapidly as the price once an interchangeable generic is approved by FDA, but putting pressure on FDA to get a generic to market may be counterproductive.

EpiPen 2-pak

Poor FDA. The agency has an awful lot of important, controversial issues in its bailiwick, but now it is being blamed for skyrocketing drug prices.

The latest example is in the flare up of concern about Mylan NV’s price increases for the epinephrine auto-injector EpiPen. In an August 24 letter to FDA Commissioner Robert Califf, Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa), Ranking member Patrick Leahy (D-Vt.), members Amy Klobuchar (D-Minn.) and Richard Blumenthal, and Sen. Ron Johnson (R-Wisc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America